The official journal of the Korean Diabetes Association (KDA), *Diabetes & Metabolism Journal* (DMJ) has finished a meaningful journey, and has been accepted to Science Citation Index Expanded (SCIE) in October, 2017. KDA has published '*The Journal of Korean Diabetes Association*' in 1972 which is the first version of the official journal (Korean version). In 2008, the journal\'s title changed to '*Korean Diabetes Journal*,' and it became an English journal given the goal of SCIE index since 2010. DMJ has been renewed to a new version in 2011 and it is published bimonthly until now. The current status of the scientific research and practice of worldwide diabetes and metabolic diseases has been published in the DMJ since its birth in 2011.

In KDA\'s 50th anniversary, DMJ was indexed in SCIE and became available at the Web of Science Core Collection. Numerous individuals--KDA\'s members, authors, reviewers, editors--have worked together to have it accepted to SCIE and to disseminate new foundational and clinical knowledge about the collective and increasingly complex co-relevancies of diabetes and metabolic diseases. I believe that DMJ is becoming a successful international journal in accordance with the efforts of the KDA to become an active contributor fighting against the threat of worldwide epidemic of diabetes. The recent trend of citation clearly conveys the enhanced reputation and status of DMJ. The number of citations in other journals and the number of article downloads in DMJ have steadily increased. DMJ has continued to maintain a high quality standard and its official status. Moreover, it is qualified to provide a high quality contents to the subscribers. DMJ is committed to contributing to the development of diabetes in education and treatment of diabetes by sharing scientific information about the latest developments in diabetology. DMJ is an international, peer-reviewed, open access, online journal, which publishes original research, reviews, and commentaries in all areas relevant to diabetes and metabolic diseases. Our outstanding DMJ publications staff has a well-deserved reputation of being very responsive to the needs of authors and reviewers.

The first impact factor (IF) of DMJ will be released this year and I expect this first IF to be high. The cover of DMJ will be renewed and the content of DMJ will also be available on new online platforms, so you can access your articles from anywhere. You will witness great innovations at the 2018 ICDM (International Congress of Diabetes and Metabolism) meeting this October in Seoul, Korea, and a special DMJ session will be held during the event. Its purpose is to invite authors of manuscripts that were scored the highest by our editors and reviewers in 2017. During this session, you will listen to original research presentations from five speakers, each representing a different subspecialty area. The speakers will describe not only their published work but also more recent unpublished information. The goals of this session are to help all of us to keep up with all of diabetology, to maintain our intellectual breadth, to provide a great opportunity for fellows and other younger scientists to gain the bully pulpit, and to celebrate the creative process of revitalizing DMJ\'s unique educational business.

Assuming the Editorship of DMJ is a great and personally modest proposal for me, our overall goal is to maintain the best of DMJ and build upon the excellent performances provided by the previous president of KDA, Myung Sik Lee, MD, PhD.; the previous chairman, Board of Directors of KDA, Moon Kyu Lee, MD, PhD.; and the previous Editors-in-chief, Hyun Shik Son, MD, PhD., Sei Hyun Baik, MD, PhD., Kyong Soo Park, MD, PhD. Among these dedicated people, I want to appoint my immediate predecessor, Kyong Soo Park. He has been an excellent role model of me. Also, I am very happy to work with the new Associate editors: Tae Seo Sohn, Cheol-Young Park, In-Kyung Jeong, Kyung Mook Choi, Kyung-Soo Kim, Jun Sung Moon, and other Editors, who represent the whole of diabetology, from bench to bedside, and will guarantee that we publish the best clinical and research work.

Our journey is not over, and now is the beginning of our journal. The DMJ can grow into a better journal only with you, the authors who send us manuscripts for peer review. This is your journal and your journey, and you are the major part of DMJ\'s future.
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